TRLV · Trulieve Cannabis Corp. · Documents

$11.56 +0.66 (+6.06%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript

Market Cap

$1.97B

170.63M

Volume · Nov 6 1.55M Avg daily vol (3M) 1.76M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $1.18B down 0.4% 10-K filed Feb 26, 2026 Quarterly report New FY2026 Q3 Revenue $230.22M down 20.1% 10-Q filed Nov 5, 2026 Latest results New Financial results 8-K filed Nov 5, 2026 Earnings call New Q3 2026 earnings call Held Nov 5, 2026

2026

Nov 5

Earnings call

Q3 2026 earnings call AI summary on its way

Nov 5

Quarterly report 10-Q FY2026 Q3, ended Sep 30

Quarterly report for FY2026 Q3 AI summary on its way

Revenue $230.22M ▼ 20.1% Net income $774K Diluted EPS $0.00

Nov 5

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

Aug 11

Current report 8-K

Entered into a material agreement, Unregistered sale of equity, Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change AI summary on its way

Aug 7

Earnings call

Q2 2026 earnings call AI summary on its way

Aug 7

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Revenue $270.95M ▼ 10.3% Net loss $406.06M

Aug 7

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure AI summary on its way

Aug 5

Current report 8-K

Shareholder vote results AI summary on its way

Jul 2

Current report 8-K Events of Jun 30

Director or officer change, or executive pay AI summary on its way

Jun 25

Proxy statement DEF 14A

Proxy statement AI summary on its way

Jun 25

Proxy statement DEFA14A

Proxy statement AI summary on its way

Jun 12

Current report 8-K Events of Jun 11

Director or officer change, or executive pay AI summary on its way

Jun 12

Proxy statement PRE 14A

Proxy statement AI summary on its way

Jun 11

Current report 8-K Events of Jun 9

Shareholder vote results AI summary on its way

Jun 9

Investor event

Annual Shareholder Meeting AI summary on its way

Jun 9

Current report 8-K

Other events AI summary on its way

Jun 4

Current report 8-K Events of Jun 3

Entered into a material agreement, Completed an acquisition or sale of assets AI summary on its way

May 7

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

May 7

Quarterly report 10-Q FY2026 Q1, ended Mar 31

Quarterly report for FY2026 Q1 AI summary on its way

Revenue $286.75M ▼ 3.7% Net income $2.28M

Apr 29

Proxy statement DEF 14A

Proxy statement AI summary on its way

Apr 29

Proxy statement DEFA14A

Proxy statement AI summary on its way

Apr 29

Annual report to holders ARS

Annual report to holders AI summary on its way

Apr 21

Current report 8-K Events of Apr 15

Director or officer change, or executive pay AI summary on its way

Mar 5

Current report 8-K Events of Feb 27

Director or officer change, or executive pay AI summary on its way

Feb 26

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

Feb 26

Annual report 10-K FY2025, ended Dec 31

Annual report for FY2025 AI summary on its way

Revenue $1.18B ▼ 0.4% Net loss $122.25M Diluted EPS -$0.58

Feb 18

Current report 8-K Events of Feb 12

Director or officer change, or executive pay AI summary on its way

Jan 29

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events AI summary on its way

2025

Dec 17

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Dec 9

Current report 8-K Events of Dec 8

Other events

Nov 5

Current report 8-K

Financial results, Regulation FD disclosure

Nov 5

Quarterly report 10-Q FY2025 Q3, ended Sep 30

Quarterly report for FY2025 Q3

Revenue $288.19M ▲ 1.4% Net loss $28.78M

Nov 4

Current report 8-K

Other events

Aug 27

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Aug 6

Current report 8-K

Financial results, Regulation FD disclosure

Aug 6

Quarterly report 10-Q FY2025 Q2, ended Jun 30

Quarterly report for FY2025 Q2

Revenue $302.09M ▼ 0.4% Net loss $16.11M

Jun 30

Registration statement S-3ASR

Registration statement

Jun 13

Current report 8-K Events of Jun 12

Director or officer change, or executive pay, Shareholder vote results

May 7

Current report 8-K

Financial results, Regulation FD disclosure

May 7

Quarterly report 10-Q FY2025 Q1, ended Mar 31

Quarterly report for FY2025 Q1

Revenue $297.76M ▲ unchanged Net loss $33.76M Diluted EPS -$0.16

Apr 30

Proxy statement DEFR14A

Proxy statement

Apr 29

Proxy statement DEF 14A

Proxy statement

Apr 29

Proxy statement DEFA14A

Proxy statement

Apr 29

Annual report to holders ARS

Annual report to holders

Mar 7

Current report 8-K Events of Mar 6

Director or officer change, or executive pay, Regulation FD disclosure

Feb 27

Current report 8-K

Financial results, Regulation FD disclosure

Feb 27

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $1.19B ▲ 5.1% Net loss $160.58M Diluted EPS -$0.79

2024

Nov 5

Current report 8-K

Financial results, Regulation FD disclosure

Nov 5

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $284.28M ▲ 3.3% Net loss $61.6M Diluted EPS -$0.32

Aug 6

Current report 8-K

Financial results, Regulation FD disclosure

Showing 1–50 of 130 documents

Key facts CIK 1754195 CUSIP 89790E106 13F (30d) 63 filings 63 filers Visit website Investor relations